Serum visfatin as predictive marker of cardiometabolic risk in women with polycystic ovary syndrome

Conclusion Serum visfatin levels could discriminate PCOS from healthy control and T2DM from NGT PCOS women. Moreover, vesfatin was positive correlated to cardio-metabolic risk factors. Interestingly, the sensitivity and specificity power of vesfatin were high. Thus, it could be early predicting of cardio-metabolic risks among PCOS women and might be useful in therapeutic intervention in future.
Source: Middle East Fertility Society Journal - Category: Reproduction Medicine Source Type: research